Alaunos Therapeutics | ZIOP - Interest Expense On Debt


Alaunos Therapeutics reported $0 in Interest Expense on Debt for its fiscal quarter ending in December of 2023.





Interest Expense On Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2023
Amgen USD 653M 32M Dec/2025
AstraZeneca USD 303M 38M Jun/2025
Baxter International USD 58M 14M Sep/2025
Biogen USD 72.6M 12.6M Jun/2025
Bioline Rx USD 360K 84K Sep/2025
Bristol-Myers Squibb USD 480M 5M Sep/2025
Celltrion KRW 19B 1.96B Jun/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Cspc Pharmaceutical CNY 10.19M 4.73M Sep/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Divis Laboratories Ltd INR 30M 20M Jun/2025
Gilead Sciences USD 254M 6M Jun/2025
GlaxoSmithKline GBP 167M 17M Sep/2025
Incyte USD 592K 2K Sep/2025
Ionis Pharmaceuticals USD 18M 1000K Sep/2025
J&J USD 18M 290M Sep/2025
Kangmei Pharma CNY 1.82M 150K Sep/2025
Knight Therapeutics CAD 2.37M 6K Sep/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
Medical Developments International AUD 18K 3K Jun/2025
Merck USD 412M 85M Dec/2025
Neuren Pharmaceuticals AUD 0 0 Jun/2024
Novartis USD 281M 8M Sep/2025
Pfizer USD 711M 59M Dec/2025
Pharma Mar EUR 117K 1.24M Sep/2025
PTC Therapeutics USD 2.64B 2.61B Sep/2025
Qiagen NV USD 8.22M 615K Sep/2025
Regeneron Pharmaceuticals USD 12.2M 7.1M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sartorius EUR 49.5M 8.1M Sep/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
TG Therapeutics USD 6.72M 4K Sep/2025
Tilray USD 6.7M 2.73M Jun/2025
Zz Pientze Pharmaceu CNY 46.05M 36.5M Jun/2025